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Abstract
Background: Lack of adherence to antiretroviral medications is one of the key challenges for paediatric HIV care
and treatment programmes. There are few hands-on opportunities for healthcare workers to gain awareness of the
psychosocial and logistic challenges that caregivers face when administering daily antiretroviral therapy to children.
This article describes an educational activity that allows healthcare workers to simulate this caregiver role.
Methods: Paediatric formulations of several antiretroviral medications were dispensed to a convenience sample of
staff at the Baylor College of Medicine-Bristol-Myers Squibb Children’s Clinical Center of Excellence in Mbabane,
Swaziland. The amounts of the medications remaining were collected and measured one week later. Adherence
rates were calculated. Following the exercise, a brief questionnaire was administered to all staff participants.
Results: The 27 clinic staff involved in the exercise had varying and low adherence rates over the week during
which the exercise was conducted. Leading perceived barriers to adherence included: “family friends don’t help me
remember/tell me I shouldn’t take it” and “forgot”. Participants reported that the exercise was useful as it allowed
them to better address the challenges faced by paediatric patients and caregivers.
Conclusions: Promoting good adherence practices among caregivers of children on antiretrovirals is challenging
but essential in the treatment of paediatric HIV. Participants in this exercise achieved poor adherence rates, but
identified with many of the barriers commonly reported by caregivers. Simulations such as this have the potential
to promote awareness of paediatric ARV adherence issues among healthcare staff and ultimately improve
adherence support and patient outcomes.
Background
Lack of adherence to antiretroviral (ARV) medications is
o n eo ft h ek e yc h a l l e n g e sf o rH I Vc a r ea n dt r e a t m e n t
programmes [1-3]. While strict adherence promotes
viral suppression, poor adherence results in further
immunosuppression and resistance to antiretroviral
medications [4,5]. Adherence is especially challenging
among young infants and children, and supervising daily
child dosing requires organizational skills, age-appropri-
ate negotiation skills, and an understanding of how to
actually draw up and administer medication to a poten-
tially uncooperative child. Handling paediatric
medication can also be a challenge, especially if dis-
pensed as a liquid formulation [6-9].
Paediatric HIV care and treatment remains a global
health priority, but health professionals providing ARVs
to children are often unaware of these complexities.
There are few training initiatives designed to ensure that
healthcare providers understand the psychosocial and
logistic challenges of taking ARVs on a daily basis. Such
an understanding of common barriers is potentially ben-
eficial to effectively discussing adherence strategies with
patients and their caretakers [10-12]. Such adherence
training exercises also promise to generate ideas and
discussion that will lead to improvements in clinical
practice and related adherence promotion strategies,
both for HIV treatment programmes and those addres-
sing other childhood diseases.
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Paediatric formulations of highly active antiretroviral
therapy (HAART) medications were dispensed on a
voluntary basis to a convenience sample of full-time
Swazi and expatriate clinical staff at the Baylor College
of Medicine-Bristol-Myers Squibb Children’s Clinical
Center of Excellence in Mbabane, Swaziland. Most clini-
cal staff working on site participated in the exercise, and
all who participated were involved in the direct provi-
sion of paediatric HIV care and treatment services.
Other clinical and non-clinical staff volunteered to offer
adherence support to participants in keeping with the
adherence support protocol of the clinic. Liquid stavu-
dine, lamivudine and nevirapine were dispensed as per
Swaziland care and treatment guidelines (2006 edition).
To avoid waste, medications that were used were com-
bined from the small volumes of leftover liquids turned
in by patients.
All participating staff attended a group adherence ses-
sion similar to that offered to caregivers of paediatric
clients initiating HAART, including a review of the
importance of adherence, the individual ARVs in the
regimen and potential adverse effects, the components
of successful adherence, and the consequences of poor
adherence. Participating staff then read and signed a
standard adherence contract and received their assigned
three-drug regimen, along with an explanation and dos-
ing calendar from our pharmacists, as per clinic proto-
col. Participants received liquid formulations of various
first-line ARVs as if each was the parent of a young
child receiving either an initial ARV regimen or a refill
of an ongoing regimen.
During the exercise, participants were asked to adhere
strictly to the appropriate schedule, carefully draw
appropriate doses, and administer the liquid into the
sink, and thus no medications were actually consumed.
Participants were requested to keep notes about the
experience and the challenges faced and to return with
any remaining medications seven days later. At that
time, each participant’s remaining doses were collected
and measured and adherence rates were calculated. Staff
adherence was calculated based on overall adherence,
which assigned an adherence rate equal to the value of
the farthest outlier of the three assigned medications,
t h es a m em e t h o du s e dr o u t i nely in the clinic to calcu-
late client adherence rates.
Each participant also completed a one-page question-
naire derived from the AIDS Clinical Trials Group Self
Report survey, which allowed self-reporting on adher-
ence rates and barriers. Each barrier included was
weighted using a numeric scale (Zero - “Never a pro-
blem"; 1 - “Hardly ever a problem"; 2 - “Frequent pro-
blem"; and 3 - “Almost always a problem”). Twelve
potential barriers were included in the questionnaire
(Table 1). Variables involving cost and side effects were
not included in the analysis as all ARVs at the Baylor
College of Medicine-Bristol-Myers Squibb Children’s
Clinical Center of Excellence are provided free of
charge, and as participants were disposing of the liquid
medicines after drawing them into a syringe, rather than
actually administering or consuming the medications.
Results
Of the clinic’s 50 staff members, 27 volunteered to par-
ticipate in the simulated adherence exercise. The partici-
pating staff members included physicians (nine), nurses
(eight), clinical support staff (eight), a pharmacist and a
social worker. More than half (15) were from Swaziland,
while the others were from North America (eight),
Kenya (two), South Africa (one) and Germany (one).
None had participated in an adherence exercise of this
type before.
Adherence among participants was poor, with only
one (4%) of the 27 participating Centre of Excellence
staff achieving 95-100% overall adherence during the
exercise. Though not possible to make a direct compari-
son, it is of interest that 46% of paediatric patients aged
five years and younger and captured in the clinic’se l e c -
tronic medical record during the month of the exercise
achieved 95-100% overall adherence.
On a five-level Likert scale ranging from “never” to
“all of the time”, 11 of the participants reported follow-
ing his/her specific schedule “all of the time”,w h i l e1 3
reported following it “most of the time”.T h er e m a i n i n g
three reported following the schedule “half” (one) or
“some” (two) of the time. The top two reported barriers
were being “too busy” and “family and/or friends don’t
help me remember”.
The general response of the participants to the exer-
cise was positive. Comments included: “This was an
eye-opening exercise”, “Very good for us to experience”,
and “Now I do relate with the challenges faced by our
clients.”
Discussion
Informed adherence counselling is difficult without a
first-hand appreciation of the difficulties inherent in
administering regularly scheduled medications. While
the clinic staff involved in this exercise understood the
importance and complexity of adherence behaviours,
few had personally experienced the challenges of daily
adherence despite working directly with the end users of
these medications on a daily basis.
The poor adherence rates among staff participants are
likely a reflection of several factors. The primary objec-
tive of achieving good adherence among participants
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achieve good adherence were not as strong as among
parents of HIV-positive children. Also, the exercise
lasted only a week, and so a single error in dosing has a
potentially large effect on the calculated adherence.
Moreover, most of the participants were handling pae-
diatric ARVs for the first time.
The leading reported barriers among patients are simi-
lar to those previously reported. While careful schedul-
ing and adherence support are routinely discussed at
length in our pre-ART adherence counselling sessions,
other challenges, such as difficulty drawing medicine
and spillage, are often not addressed.
Conclusions
Good adherence to liquid formulations of ARVs is chal-
lenging but essential in the treatment of paediatric HIV.
When asked to adopt and simulate a typical paediatric
ARV dosing schedule for a week-long exercise, our
healthcare workers achieved poor adherence compared
with our patient population, but identified with many of
the barriers commonly reported by caregivers. With few
opportunities to learn first hand what strict adherence
to ARVs entails, simulatio n ss u c ha st h i sh a v et h e
potential to promote awareness of paediatric ARV
adherence issues and empower healthcare staff to more
effectively counsel caregivers and children taking ARVs,
as well as other medications.
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